This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1976 Nov-Dec;19(3):203-34.

doi: 10.1016/0033-0620(76)90016-5.

The clinical pharmacology of beta-adrenoceptor-blocking drugs

M E Conolly, F Kersting, C T Dollery

PMID: 10600
DOI: 10.1016/0033-0620(76)90016-5

Review

The clinical pharmacology of beta-adrenoceptor-blocking drugs

M E Conolly et al. Prog Cardiovasc Dis. 1976 Nov-Dec.

. 1976 Nov-Dec;19(3):203-34.

doi: 10.1016/0033-0620(76)90016-5.

Authors

M E Conolly, F Kersting, C T Dollery

PMID: 10600
DOI: 10.1016/0033-0620(76)90016-5

No abstract available

PubMed Disclaimer

Similar articles

[Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
Witkowska M. Witkowska M. Kardiol Pol. 1982;25(2):147-61. Kardiol Pol. 1982. PMID: 6125621 Review. Polish. No abstract available.
Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
Harrison DC. Harrison DC. Drugs. 1974;7(1):1-7. doi: 10.2165/00003495-197407010-00001. Drugs. 1974. PMID: 4152164 No abstract available.
[The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension].
Lydtin H. Lydtin H. Med Welt. 1975 Aug 29;6(35):1487-92. Med Welt. 1975. PMID: 240998 German. No abstract available.
In vitro assessment of the selectivities of various beta-adrenergic blocking agents.
Dreyer AC, Offermeier J. Dreyer AC, et al. Life Sci. 1980 Dec 1;27(22):2087-92. doi: 10.1016/0024-3205(80)90489-0. Life Sci. 1980. PMID: 6111008 No abstract available.
Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.
Lowenthal DT, Saris SD, Packer J, Haratz A, Conry K. Lowenthal DT, et al. Am J Med. 1984 Oct 5;77(4A):119-27. doi: 10.1016/s0002-9343(84)80047-9. Am J Med. 1984. PMID: 6148890 Review.

See all similar articles

Cited by

Right ventricular performance in essential hypertension after beta-blockade.
Ferlinz J, Easthope JL, Hughes D, Siegel J, Tobis J, Aronow WS. Ferlinz J, et al. Br Heart J. 1981 Jul;46(1):23-9. doi: 10.1136/hrt.46.1.23. Br Heart J. 1981. PMID: 7023516 Free PMC article. Clinical Trial.
Effect of a bradycardic agent on the isolated blood-perfused canine heart.
Schipke JD, Harasawa Y, Sugiura S, Alexander J Jr, Burkhoff D. Schipke JD, et al. Cardiovasc Drugs Ther. 1991 Apr;5(2):481-8. doi: 10.1007/BF03029773. Cardiovasc Drugs Ther. 1991. PMID: 1854656 Review.
A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.
Saunders J, Gomeni R, Kilborn JR, Morselli PL, Sönksen PH. Saunders J, et al. Eur J Clin Pharmacol. 1981;21(3):177-84. doi: 10.1007/BF00627917. Eur J Clin Pharmacol. 1981. PMID: 6119203
beta 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivo.
Copeland JG, Larson DF, Roeske WR, Russell DH, Womble JR. Copeland JG, et al. Br J Pharmacol. 1982 Mar;75(3):479-83. doi: 10.1111/j.1476-5381.1982.tb09164.x. Br J Pharmacol. 1982. PMID: 6121595 Free PMC article.
Low-dose propranolol for the protection of the left ventricle from ischaemic damage.
Brown AH, Krause BL, Morritt GM. Brown AH, et al. Thorax. 1981 Nov;36(11):814-22. doi: 10.1136/thx.36.11.814. Thorax. 1981. PMID: 7330803 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science